Clinical Trial Update: Optimizing HBV Management During Anti-CD20 Antibodies

View source ↗

Summary

This clinical trial update from The University of Hong Kong discusses optimizing management of Hepatitis B in patients receiving anti-CD20 antibody therapies, f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Anti-CD20 monoclonal antibodies

Snippet

Sponsor: The University of Hong Kong | Conditions: Liver Dysfunction, Immune Suppression | Status: COMPLETED